Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0CT8A
|
|||
| Former ID |
DNC004946
|
|||
| Drug Name |
4-(3,4-Diethoxy-benzylamino)-benzamidine
|
|||
| Synonyms |
benzylamine 5; CHEMBL181265; BDBM13579
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H23N3O2
|
|||
| Canonical SMILES |
CCOC1=C(C=C(C=C1)CNC2=CC=C(C=C2)C(=N)N)OCC
|
|||
| InChI |
1S/C18H23N3O2/c1-3-22-16-10-5-13(11-17(16)23-4-2)12-21-15-8-6-14(7-9-15)18(19)20/h5-11,21H,3-4,12H2,1-2H3,(H3,19,20)
|
|||
| InChIKey |
KWXVDUACPKJCCN-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors. Bioorg Med Chem Lett. 2005 Feb 1;15(3):817-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.